Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles.

MLA

Green, Neal, et al. “Inhibitors of Tumor Progression Loci-2 (Tpl2) Kinase and Tumor Necrosis Factor Alpha (TNF-Alpha) Production: Selectivity and in Vivo Antiinflammatory Activity of Novel 8-Substituted-4-Anilino-6-Aminoquinoline-3-Carbonitriles.” Journal of Medicinal Chemistry, vol. 50, no. 19, Sept. 2007, pp. 4728–45. EBSCOhost, https://doi.org/10.1021/jm070436q.

APA

Green, N., Hu, Y., Janz, K., Li, H.-Q., Kaila, N., Guler, S., Thomason, J., Joseph-McCarthy, D., Tam, S. Y., Hotchandani, R., Wu, J., Huang, A., Wang, Q., Leung, L., Pelker, J., Marusic, S., Hsu, S., Telliez, J.-B., Hall, J. P., … Lin, L.-L. (2007). Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles. Journal of Medicinal Chemistry, 50(19), 4728–4745. https://doi.org/10.1021/jm070436q

Chicago

Green, Neal, Yonghan Hu, Kristin Janz, Huan-Qiu Li, Neelu Kaila, Satenig Guler, Jennifer Thomason, et al. 2007. “Inhibitors of Tumor Progression Loci-2 (Tpl2) Kinase and Tumor Necrosis Factor Alpha (TNF-Alpha) Production: Selectivity and in Vivo Antiinflammatory Activity of Novel 8-Substituted-4-Anilino-6-Aminoquinoline-3-Carbonitriles.” Journal of Medicinal Chemistry 50 (19): 4728–45. doi:10.1021/jm070436q.